Frekil vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Frekil is a digital health platform focused on mental health support, offering AI-assisted therapy tools and care coordination for individuals managing anxiety, depression, and stress.
About
Frekil is a mental health technology company developing digital tools that expand access to mental health support by combining AI-assisted therapeutic interventions with human care coordination. Mental health care access remains severely constrained by therapist availability, insurance coverage gaps, and social stigma—Frekil's digital-first approach addresses these barriers by providing structured support between clinical appointments and entry-level care for individuals who can't access traditional therapy.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.